Exact Mass: 419.0190698

Exact Mass Matches: 419.0190698

Found 14 metabolites which its exact mass value is equals to given mass value 419.0190698, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

   

(E)-3-(13,13-dibromotrideca-1,12-dienyl)-2H-azirine-2-carboxylic acid|motualevic acid F

(E)-3-(13,13-dibromotrideca-1,12-dienyl)-2H-azirine-2-carboxylic acid|motualevic acid F

C16H23Br2NO2 (419.0095418)


   
   

2-[(3-iodo-6-nitroindazol-1-yl)methoxy]ethyl-trimethylsilane

2-[(3-iodo-6-nitroindazol-1-yl)methoxy]ethyl-trimethylsilane

C13H18IN3O3Si (419.0162148)


   
   

Ethyl 6-bromo-5-hydroxy-1-methyl-2-(phenylsulfanylmethyl)indole-3-carboxylate

Ethyl 6-bromo-5-hydroxy-1-methyl-2-(phenylsulfanylmethyl)indole-3-carboxylate

C19H18BrNO3S (419.0190698)


   

Clopidogrel bisulfate

Clopidogrel bisulfate

C16H18ClNO6S2 (419.0264038)


C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent > C190801 - P2Y12 Inhibitor D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors Clopidogrel hydrogen sulfate is an antiplatelet agent to prevent blood clots. Clopidogrel hydrogen sulfate inhibits CYP2B6 and CYP2C19 with IC50s of 18.2 nM and 524 nM, respectively[1]. Clopidogrel hydrogen sulfate is a potent antithrombotic agent that inhibits ADP-induced platelet aggregation[2].Clopidogrel hydrogen sulfate also is an orally active P2Y(12) inhibitor[5].

   

iron(3+),tribenzoate

iron(3+),tribenzoate

C21H15FeO6 (419.021798)


   

(S)-5,5-Dioxo-9-((3,3,3-trifluoro-2-hydroxy-2-methylpropanoyl)amino)-4,10-dihydrothieno(3,2-C)(1)benzothiepin-10-one

(S)-5,5-Dioxo-9-((3,3,3-trifluoro-2-hydroxy-2-methylpropanoyl)amino)-4,10-dihydrothieno(3,2-C)(1)benzothiepin-10-one

C16H12F3NO5S2 (419.0108978)


   

Plavix

Plavix

C16H18ClNO6S2 (419.0264038)


D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors

   

Motualevic acid F

Motualevic acid F

C16H23Br2NO2 (419.0095418)


A 2H-azirine that is 2H-azirene-2-carboxylic acid substituted by a 13,13-dibromotrideca-1,12-dien-1-yl group at position 3 (the 2R stereoisomer). It is isolated from the marine sponge Siliquariaspongia sp. and exhibits antibacterial properties.

   

(Rac)-PT2399

(Rac)-PT2399

C17H10F5NO4S (419.0250680000001)


(Rac)-PT2399 (Compound 10e), the racemate of PT2399, acts as a potent and specific hypoxia-inducible factor 2a (HIF-2α) inhibitor with an IC50 of 0.01 μM[1].

   

PT2399

PT2399

C17H10F5NO4S (419.0250680000001)


PT2399 is a potent and selective HIF-2α antagonist, which directly binds to HIF-2α PAS B domain with an IC50 of 6 nM. PT2399 displays potent antitumor activity in vivo[1][2][3].

   

SDZ 220-040

SDZ 220-040

C16H16Cl2NO6P (419.00922660000003)


SDZ 220-040 is a competitive the mammalian NMDA receptor antagonist[1].